IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
Markus Chmielewski(University of Cologne), Hinrich Abken(Leibniz Association)
Cited by 541
Related Papers
IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells
|Cells|2020|96
An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL
|Cell Reports Medicine|2024|13
Magnetic CAR T cell purification using an anti-G4S linker antibody
|Journal of Immunological Methods|2024|3